Outcomes of Hypofractional Tomotherapy in Patients with Stage III Nonsmall Cell Lung Cancer Who Are Not Eligible for Surgery or Concurrent Chemoradiation
Table 1
Clinical characteristics and outcomes of the 43 enrolled patients.
Characteristic
No. of patients
Dose regimen
<19 f
≥19 f
TNM stage
IIIa
27
9
18
0.888
IIIb
16
5
11
T stage
T1-2
11
3
8
1.000
T3-4
32
11
21
N stage
N0-2
33
11
22
1.000
N3
10
3
7
Age
<80.5
37
13
24
0.645
≥80.5
6
1
5
Location
Central
22
7
15
0.916
Peripheral
21
7
14
Chemotherapy history
Yes
15
5
10
1.000
No
28
9
19
Gender
Male
31
10
21
1.000
Female
12
4
8
Targeted drug
Yes
6
2
4
1.000
No
37
12
25
KPS
<90
27
7
20
0.228
≥90
16
7
9
Histology
Adenocarchnoma
12
2
10
0.382
Squamous cell
21
8
13
Others
10
4
6
Data presented as frequencies unless indicated otherwise. KPS: Karnofsky performance score.
